Abstract 4493
Background
Snail is a transcriptional repressor that promotes epithelial-to-mesenchymal transition (EMT). Snail is upregulated in breast cancer and it is associated with chromosomal instability (CIN) and metastasis. The mitotic spindle assembly checkpoint (SAC) is a critical mechanism to prevent CIN. Extensive studies have investigated signaling pathways that involve in protein-protein interactions and post translational modifications. However, it not known how mitosis might be impacted by transcriptional regulation. Due to the fact that Snail is a transcriptional regulator and that Snail is upregulated in breast cancer with CIN, it is critical to understand whether and how abnormally regulated Snail contributes to breast cancer CIN via transcriptional regulation.
Methods
We used siRNA to knockdown Snail in breast caner cell lines to look for a change in SAC. We developed a phosphor-specific antibody to study Aurora-B mediated phosphorylation. Site specific mutagenesis was used to generate phosphorylation site mutants, and exogenous proteins were expressed in cells to look for an effect in SAC and CIN.
Results
We found that Snail is an essential element that is required for the SAC. Genetic depletion of Snail in breast cancer cells by siRNA led to a defect in activation of SAC (measured by accumulation of Histone Serine 10 phosphorylation in response to spindle damaging agents). Interestingly we also found that the Snail protein level was significantly enhanced in the presence of nocodazole. Further, we found that Snail upregulation was through phosphorylation in an Aurora-B dependent manner. We identified a serine site that can be phosphorylated by Aurora-B. Using a phosphor-specific antibody we have developed, we further proved that the phosphorylation event was initiated in mitosis. Functional studies reveal a critical role for Snail phosphorylation in activation of the SAC and prevention of CIN.
Conclusions
1. Snail is required for mitotic spindle checkpoint activation; 2. Snail is phosphorylated by Aurora B in mitosis; 3. Aurora-B medicated Snail phosphorylation is required for optinal activation of the spindle checkpoint and prevention of chromosomal instability in breast cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Tianjin Medical University Cancer Institute and Hospital.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2122 - The role of EGFR inhibitor (EGFRi) in immune cell infiltration and CD8+ T-cell activation in EGFR mutant lung cancer
Presenter: Fenge Li
Session: Poster Discussion session - Basic science
Resources:
Abstract
5436 - The mutational signature of spontaneously developing tumors in MLH1-/- mice – potential consequences for immunotherapeutic approaches
Presenter: Claudia Maletzki
Session: Poster Discussion session - Basic science
Resources:
Abstract
1051 - Synergistic anti-cancer activity of auranofin with anti-PD-L1 therapy in triple-negative breast cancer
Presenter: Prahlad Raninga
Session: Poster Discussion session - Basic science
Resources:
Abstract
3759 - Identification of a Radio-Immune Signature with High Prognostic Value in Surgically Resected NSCLC
Presenter: Giulia Mazzaschi
Session: Poster Discussion session - Basic science
Resources:
Abstract
4275 - Automatic interpretation of cancer genomes creates the largest repository of tumor genetic driver events
Presenter: Francisco Martínez Jiménez
Session: Poster Discussion session - Basic science
Resources:
Abstract
4745 - Functional Cell Profiling (FCP) of _100,000 CTCs from multiple cancer types identifies morphologically distinguishable CTC subtypes within and between cancer types
Presenter: Adam Jendrisak
Session: Poster Discussion session - Basic science
Resources:
Abstract
816 - Aspartate-_-hydroxylase drives hepatocelluar carcinoma progression to metastasis fueling glutamine via HIF1_-mediated mitophagy
Presenter: Ran Xue
Session: Poster Discussion session - Basic science
Resources:
Abstract
2774 - HORAS5 promotes cabazitaxel resistance in castration resistant prostate cancer via a BCL2A1-dependent survival mechanism
Presenter: Perla Pucci
Session: Poster Discussion session - Basic science
Resources:
Abstract
4166 - Comprehensive genomic profiling (CGP) of carcinoma of unknown primary origin (CUP): Retrospective molecular classification of potentially eligible patients (pts) for targeted or immunotherapy treatment (tx) using the prospective CUPISCO trial’s criteria
Presenter: Jeffrey Ross
Session: Poster Discussion session - Basic science
Resources:
Abstract
Poster Discussion session - Basic science - Invited Discussant 5PD, 6PD, 7PD and 1982PD
Presenter: Sheila Singh
Session: Poster Discussion session - Basic science
Resources:
Slides
Webcast